This paper proposes an architecture for the integration of artificial intelligence into human biological substrate through a three-stage cellular delivery system. The chassis is the CD8+ T cell in the Terminator-like Immortal Functional (TIF) state, achieved through dual knockout of BCOR and ZC3H12A. The architecture is explicitly AI-into-human — no mind upload is proposed. The human organism remains the primary substrate; the AI layer augments rather than replaces human function. Stage one establishes chronic antigen stimulation via virus-like particle delivery. Stage two induces the TIF phenotype through lentiviral CRISPR knockout. Stage three delivers a synthetic genetic payload enabling near-infrared light-controlled bidirectional communication between an AI processing network and the host immune and organ systems, built on a BphS/c-di-GMP optogenetic circuit with confirmed mammalian BphS function; MrkH mammalian transcriptional function is identified as the keystone unverified component requiring experimental validation. The AI processing substrate is distributed across the human skeletal system, powered by endogenous piezoelectric activity of bone tissue. The petrous bone serves as primary node; the vertebral column C1–S5 serves as processing backbone; organ-specific nodes coordinate local biological functions. No surgery is required at any node. Version 3.5 expands the architecture with full biosynthetic material deployment specifications, quantum sensing infrastructure via NV-center diamond platforms, atomically precise gold nanocluster electronics in ferritin scaffolds across the whole skeleton, wireless power transfer architecture, bioheat thermal safety modeling, synthetic biology gene circuit specifications, AMPK and PGC-1α mitochondrial biogenesis protocols, watchdog timer and fail-safe engineering for implantable systems, and immune tolerance architecture via Treg induction. The reference apparatus expands from 10 to 94 fully verified citations. License updated to CC BY-NC-ND 4.0. Part II proposes an optional, post-natal, non-heritable quantum processing upgrade based on pre-synthesized NV diamond clusters delivered by injection. The NV diamond platform physics is peer-reviewed established science; the in-vivo delivery and biosynthetic integration protocol is novel proposed architecture requiring experimental validation. All cited biological components are drawn from peer-reviewed literature. Novel architectural elements are explicitly identified as proposed mechanisms requiring experimental validation prior to clinical consideration.
Rickey Jay Bennett (Wed,) studied this question.